{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:53:23Z","timestamp":1781639603654,"version":"3.54.5"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Maturity-onset diabetes of the young type 13 (MODY13) is a rare autosomal dominant monogenic diabetes caused by mutations in the potassium inwardly rectifying channel subfamily J member 11 (KCNJ11) gene. It can mimic both type 1 and type 2 diabetes mellitus (T1DM and T2DM), making accurate diagnosis challenging.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>We describe the case of a five-year-old boy with overlapping features of T1DM and T2DM. He presented with hyperglycemia, obesity, and acanthosis nigricans. These symptoms improved after losing 11\u00a0kg owing to lifestyle modifications. His hemoglobin A1c (HbA1c) level decreased from 9.6% to 5.8%, and the continuous glucose monitoring system (CGMS) showed 91% time in range (TIR). Eighteen months later, he developed postprandial hyperglycemia and tested positive for T1DM antibodies, prompting the administration of insulin at 0.7 U\/kg\/day. His glucose levels continued to fluctuate. Whole-exome sequencing identified a likely pathogenic KCNJ11 variant (NM_000525.3, c.574\u00a0C\u2009&gt;\u2009T, p.Arg192Cys), confirming the diagnosis of heterozygous autosomal dominant MODY13. He was then started on oral glibenclamide at 0.2\u00a0mg\/kg\/day, which lowered his HbA1c level to 7.5% and raised his CGMS TIR readings to 70%; however, insulin dependence persisted because of ongoing autoimmune \u03b2\u2011cell destruction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This case demonstrates the diagnostic challenge in pediatric diabetes when the features of T1DM, T2DM, and MODY overlap. Prompt genetic testing can lead to precise therapy. The simultaneous appearance of MODY13 and autoimmunity suggests possible interactions between the gene and the immune system.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12887-026-06672-2","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T06:16:19Z","timestamp":1772432179000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["KCNJ11 (p.Arg192Cys)\u2013associated MODY13 with coexisting autoimmunity in a child, a case report"],"prefix":"10.1186","volume":"26","author":[{"given":"Tarah H.","family":"Fatani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"key":"6672_CR1","unstructured":"Sarafoglou K, Hoffmann GF, Roth KS, editors. In: Pediatric Endocrinology and Inborn Errors of Metabolism, 2e. edn. New York, NY: McGraw-Hill Education; 2017."},{"key":"6672_CR2","unstructured":"Kappy MS, Allen DB, Geffner ME. In: Pediatric Practice: Endocrinology, 2e. edn. New York, NY: McGraw-Hill Education; 2013."},{"key":"6672_CR3","doi-asserted-by":"crossref","unstructured":"Diabetes Mellitus. In. Practical Endocrinology and Diabetes in Children. edn.: Malcom D.C. Donaldson; 2019. pp. 1\u201356.","DOI":"10.1002\/9781119386230.ch1"},{"key":"6672_CR4","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.2147\/DMSO.S179793","volume":"12","author":"T Urakami","year":"2019","unstructured":"Urakami T. Maturity-onset diabetes of the young (MODY): current perspectives on diagnosis and treatment. Diabetes Metab Syndr Obes. 2019;12:1047\u201356.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"8","key":"6672_CR5","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1111\/pedi.13426","volume":"23","author":"SAW Greeley","year":"2022","unstructured":"Greeley SAW, Polak M, Nj\u00f8lstad PR, Barbetti F, Williams R, Castano L, Raile K, Chi DV, Habeb A, Hattersley AT, et al. ISPAD Clinical Practice Consensus Guidelines 2022: The diagnosis and management of monogenic diabetes in children and adolescents. Pediatr Diabetes. 2022;23(8):1188\u2013211.","journal-title":"Pediatr Diabetes"},{"issue":"20","key":"6672_CR6","doi-asserted-by":"publisher","first-page":"9436","DOI":"10.3390\/app11209436","volume":"11","author":"A Tshivhase","year":"2021","unstructured":"Tshivhase A, Matsha T, Raghubeer S. Diagnosis and Treatment of MODY: An Updated Mini Review. Appl Sci. 2021;11(20):9436.","journal-title":"Appl Sci"},{"issue":"3","key":"6672_CR7","doi-asserted-by":"publisher","first-page":"e13520","DOI":"10.1111\/1753-0407.13520","volume":"16","author":"Y Chen","year":"2024","unstructured":"Chen Y, Hu X, Zhao M. Clinical and genetic characteristics of maturity-onset diabetes of the young type 13: A systematic review of the literature. J Diabetes. 2024;16(3):e13520.","journal-title":"J Diabetes"},{"issue":"6","key":"6672_CR8","doi-asserted-by":"publisher","first-page":"e37423","DOI":"10.1371\/journal.pone.0037423","volume":"7","author":"A Bonnefond","year":"2012","unstructured":"Bonnefond A, Philippe J, Durand E, Dechaume A, Huyvaert M, Montagne L, Marre M, Balkau B, Fajardy I, Vambergue A, et al. Whole-exome sequencing and high throughput genotyping identified KCNJ11 as the thirteenth MODY gene. PLoS ONE. 2012;7(6):e37423.","journal-title":"PLoS ONE"},{"issue":"8","key":"6672_CR9","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S2213-8587(18)30106-2","volume":"6","author":"P Bowman","year":"2018","unstructured":"Bowman P, Sulen \u00c5, Barbetti F, Beltrand J, Svalastoga P, Codner E, Tessmann EH, Juliusson PB, Skrivarhaug T, Pearson ER, et al. Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study. Lancet Diabetes Endocrinol. 2018;6(8):637\u201346.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"6672_CR10","doi-asserted-by":"crossref","unstructured":"Devaraja J, Elder C, Scott A. Non classic presentations of a genetic mutation typically associated with transient neonatal diabetes. Endocrinol Diabetes Metab Case Rep. 2020;2020:20-0122.","DOI":"10.1530\/EDM-19-0125"},{"issue":"18","key":"6672_CR11","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1056\/NEJMoa032922","volume":"350","author":"AL Gloyn","year":"2004","unstructured":"Gloyn AL, Pearson ER, Antcliff JF, Proks P, Bruining GJ, Slingerland AS, Howard N, Srinivasan S, Silva JM, Molnes J, et al. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med. 2004;350(18):1838\u201349.","journal-title":"N Engl J Med"},{"key":"6672_CR12","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.pcad.2024.03.004","volume":"85","author":"K Ze\u010devi\u0107","year":"2024","unstructured":"Ze\u010devi\u0107 K, Vol\u010dan\u0161ek \u0160, Katsiki N, Rizzo M, Milardovi\u0107 TM, Stoian AP, Banach M, Muzurovi\u0107 E. Maturity-onset diabetes of the young (MODY) - in search of ideal diagnostic criteria and precise treatment. Prog Cardiovasc Dis. 2024;85:14\u201325.","journal-title":"Prog Cardiovasc Dis"},{"issue":"4","key":"6672_CR13","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1007\/s00125-008-0942-y","volume":"51","author":"S Ellard","year":"2008","unstructured":"Ellard S, Bellann\u00e9-Chantelot C, Hattersley AT. Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young. Diabetologia. 2008;51(4):546\u201353.","journal-title":"Diabetologia"},{"key":"6672_CR14","doi-asserted-by":"crossref","unstructured":"Butnariu LI, Bizim DA, Oltean C, Rusu C, P\u00e2nzaru MC, P\u0103duraru G, et al. The Importance of Molecular Genetic Testing for Precision Diagnostics, Management, and Genetic Counseling in MODY Patients. Int J Mol Sci. 2024;25(12):6534.","DOI":"10.3390\/ijms25126318"},{"issue":"1","key":"6672_CR15","doi-asserted-by":"publisher","first-page":"8155443","DOI":"10.1155\/pedi\/8155443","volume":"2025","author":"Y Ding","year":"2025","unstructured":"Ding Y, Zhang Q, Gao S, Li J, Chang G, Wang Y, Wang L, Li X, Chen Y, Yao R-, et al. Focusing on Rare Variants Related to Maturity-Onset Diabetes of the Young in Children. Pediatr Diabetes. 2025;2025(1):8155443.","journal-title":"Pediatr Diabetes"},{"issue":"1","key":"6672_CR16","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s12902-021-00891-7","volume":"21","author":"I Rafique","year":"2021","unstructured":"Rafique I, Mir A, Saqib MAN, Naeem M, Marchand L, Polychronakos C. Causal variants in Maturity Onset Diabetes of the Young (MODY) - A systematic review. BMC Endocr Disord. 2021;21(1):223.","journal-title":"BMC Endocr Disord"},{"key":"6672_CR17","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13098-020-00557-9","volume":"12","author":"R Peixoto-Barbosa","year":"2020","unstructured":"Peixoto-Barbosa R, Reis AF, Giuffrida FMA. Update on clinical screening of maturity-onset diabetes of the young (MODY). Diabetol Metab Syndr. 2020;12:50.","journal-title":"Diabetol Metab Syndr"},{"issue":"2","key":"6672_CR18","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s12020-024-03873-6","volume":"86","author":"X Lv","year":"2024","unstructured":"Lv X, Gao J, Yang J, Zou Y, Chen J, Sun Y, Song J, Liu Y, Wang L, Xia L, et al. Clinical and functional characterization of a novel KCNJ11 (c.101G\u2009>\u2009A, p.R34H) mutation associated with maturity-onset diabetes mellitus of the young type 13. Endocrine. 2024;86(2):515\u201327.","journal-title":"Endocrine"},{"issue":"12","key":"6672_CR19","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1007\/s00125-013-3031-9","volume":"56","author":"L Liu","year":"2013","unstructured":"Liu L, Nagashima K, Yasuda T, Liu Y, Hu HR, He G, Feng B, Zhao M, Zhuang L, Zheng T, et al. Mutations in KCNJ11 are associated with the development of autosomal dominant, early-onset type 2 diabetes. Diabetologia. 2013;56(12):2609\u201318.","journal-title":"Diabetologia"},{"key":"6672_CR20","doi-asserted-by":"crossref","unstructured":"Aarthy R, Aston-Mourney K, Mikocka-Walus A, Radha V, Amutha A, Anjana R, Unnikrishnan R, Mohan V. Clinical features, complications and treatment of rarer forms of maturity-onset diabetes of the young (MODY) - A review. J Diabetes Complicat. 2020;34(10):107640.","DOI":"10.1016\/j.jdiacomp.2020.107640"},{"key":"6672_CR21","first-page":"101043","volume":"38","author":"C Chen","year":"2024","unstructured":"Chen C, Piao Y, Sang Y. A synonymous KCNJ11 variant leading to MODY13: A case report and literature review. Mol Genet Metab Rep. 2024;38:101043.","journal-title":"Mol Genet Metab Rep"},{"key":"6672_CR22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/1753-0407.13114","volume":"13","author":"B He","year":"2020","unstructured":"He B, Li X, Zhou Z. Continuous spectrum of glucose dysmetabolism due to the KCNJ11 gene mutation\u2014Case reports and review of the literature. J Diabetes. 2020;13:19\u201332.","journal-title":"J Diabetes"},{"key":"6672_CR23","doi-asserted-by":"publisher","first-page":"e230239","DOI":"10.20945\/2359-4292-2023-0239","volume":"68","author":"M Narasimhegowda","year":"2024","unstructured":"Narasimhegowda M, Nagarajappa VH, Palany R. A case series of maturity-onset diabetes of the young highlighting atypical presentations and the implications of genetic diagnosis. Arch Endocrinol Metab. 2024;68:e230239.","journal-title":"Arch Endocrinol Metab"},{"issue":"39","key":"6672_CR24","doi-asserted-by":"publisher","first-page":"e30668","DOI":"10.1097\/MD.0000000000030668","volume":"101","author":"X Song","year":"2022","unstructured":"Song X, Cao Y, Ye J, Dai W, Zhang S, Ye S. A new mutation c.685G\u2009>\u2009A:p.E229K in the KCNJ11 gene: A case report of maturity-onset diabetes of the young13. Medicine. 2022;101(39):e30668.","journal-title":"Medicine"},{"key":"6672_CR25","doi-asserted-by":"crossref","unstructured":"Goncalves J, Ferreira HU, Ribeiro S, Fernandes da Rocha D, Souto SB, Pedro J, Freitas P, Queiros J. Challenges in diagnosis and treatment of KCNJ11-MODY. Endocrinol Diabetes Metab Case Rep. 2024;2024(4):24-0081.","DOI":"10.1530\/EDM-24-0048"},{"key":"6672_CR26","doi-asserted-by":"crossref","unstructured":"Demirci D, Darendeliler F, Poyrazoglu S, Al ADK, Gul N, Tutuncu Y, Gulfidan G, Ar\u011fa K, Cac\u0131na C, Ozturk O et al. Monogenic Childhood Diabetes: Dissecting Clinical Heterogeneity by Next-Generation Sequencing in Maturity-Onset Diabetes of the Young. OMICS.2021.","DOI":"10.1089\/omi.2021.0081"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-026-06672-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-06672-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-06672-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:08:02Z","timestamp":1781636882000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12887-026-06672-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6672"],"URL":"https:\/\/doi.org\/10.1186\/s12887-026-06672-2","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,2]]},"assertion":[{"value":"29 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent for publication, including genetic test results, was obtained from the parents. The study was approved by the research ethics committee at King Abdulaziz University Hospital, Jeddah, Saudi Arabia. The committee\u2019s reference number is 523\u2009\u2212\u200925. Non-intervention (Case Report).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent to publish the clinical details was obtained from the patient\u2019s parents. A copy of the consent form is available for review by the editor of the journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"273"}}